Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure (Q39430646)

11 September 2017

Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure (English)

1 reference

11 September 2017

0 references

1 reference

Poliovirus

1 reference

Matthew Bates

6

0 references

author name string

Marta Sanz-Ramos

1

1 reference

11 September 2017

Daniela Manno

2

1 reference

11 September 2017

Mirriam Kapambwe

3

1 reference

11 September 2017

Ida Ndumba

4

1 reference

11 September 2017

Kunda G Musonda

5

1 reference

11 September 2017

Julia Chibumbya

7

1 reference

11 September 2017

Joshua Siame

8

1 reference

11 September 2017

Mwaka Monze

9

1 reference

11 September 2017

Suzanne Filteau

10

1 reference

11 September 2017

Ursula A Gompels

11

1 reference

11 September 2017

CIGNIS study team

12

1 reference

11 September 2017

language of work or name

English

0 references

publication date

6 March 2013

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

16

1 reference

11 September 2017

2042-2049

1 reference

Highly active antiretroviral treatment for the prevention of HIV transmission

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Immunization for persons infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Cytomegalovirus and human immunosenescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Specific Cell-Mediated Immunity and the Natural History of Congenital Infection with Cytomegalovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

inferred from DOI database lookup

7 January 2021

based on heuristic

Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Impaired humoral response to vaccines among HIV-exposed uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

The polio-eradication programme and issues of the end game

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Safety and immunogenicity of bacille Calmette-Guérin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Declining HIV prevalence among young pregnant women in Lusaka, Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Micronutrient fortification to improve growth and health of maternally HIV-unexposed and exposed Zambian infants: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Determinants of infant feeding choices by Zambian mothers: a mixed quantitative and qualitative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

A micronutrient-fortified food enhances iron and selenium status of Zambian infants but has limited efficacy on zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Effect of breast-feeding on antibody response to conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Nutritionally mediated programming of the developing immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.044

10.1016/J.VACCINE.2013.02.044

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference